THURSDAY, Sept. 14, 2017 -- A small Australian study suggests that consuming high amounts of artificial sweeteners might affect how the body responds to sugar -- and might raise a person's risk of diabetes.
"This study supports the concept that artificial sweeteners could reduce the body's control of blood sugar levels," said lead author Richard Young, an associate professor at the University of Adelaide's medical school.
WEDNESDAY, Sept. 13, 2017 -- Type 2 diabetes can reduce your chances for a rare but potentially fatal weakness of blood vessels, a new study says. But while this may sound like good news, it's not.
Swedish investigators found that type 2 diabetes significantly decreases the long-term risks of aortic aneurysm and aortic dissection, two conditions that can lead to internal bleeding due to rupture of blood vessels.
WEDNESDAY, Sept. 13, 2017 -- Millions of Americans with type 2 diabetes and pre-diabetes are at risk for chronic kidney disease, and another 59,000 Americans, 40 and older, are at risk for diabetes-related blindness.
That's the sobering conclusion of new research by investigators at the U.S. Centers for Disease Control and Prevention.
WEDNESDAY, Aug. 9, 2017 -- A small clinical trial showed an immune system therapy was safe for people with type 1 diabetes, British researchers report.
The immunotherapy also showed signs of helping to keep insulin production steady in people newly diagnosed with the disease, the study authors said. However, because this was a placebo-controlled safety trial, there weren't enough people included to know for sure how well the treatment works.
THURSDAY, July 27, 2017 -- That glass of wine or pint of beer you enjoy with dinner every night might come with an added benefit -- a lower risk of type 2 diabetes, a new Danish study contends.
The researchers found that men who had 14 drinks each week and women who had nine drinks a week appeared to have the lowest risk of type 2 diabetes, compared to nondrinkers or people who drank more heavily, said senior researcher Janne Tolstrup.